Cancer-causing Chemicals Found in More Blood Pressure Medications


Blood Pressure Medication Containing Carcinogen Recalled
 
On Jan. 23, 2019, one of the nation's leading pharmaceutical manufacturers, Torrent Pharmaceuticals, announced a voluntary recall of a popular blood pressure medication.
 
The recalled medication is a combination tablet containing both losartan potassium and hydroclorothiazide, also known as HTCZ. Torrent's voluntary recall now includes a total of 16 lots of these combo tablets.

The medication has been recalled due to trace amounts of a carcinogenic material, Nitrosodiethylamine, or NDEA, being found in the active ingredient losartan.
 
The losartan at issue is an active ingredient that was manufactured at Hetero Labs Limited.

Voluntary Recall Is Only a Precaution

 
Torrent is voluntarily recalling only the medication lots that contain NDEA levels above the recommended levels. The recommended amount of NDEA is not to exceed .27 ppm (parts per million). NDEA is a chemical that has been associated with cancer.

The Food and Drug Administration (FDA) advises the public that any medications that are hydroclorothiazide HCTZ-only or amlodipine-only are not a part of this medicine recall.

Only Combo Tabs Involved in Drug Recall

Pharmaceutical manufacturers have voluntarily recalled high blood medicines that are amlodipine combined with either valsartan or losartan, or HCTZ combined with either valsartan or losartan.

Losartan is commonly prescribed as a way to treat high blood pressure, also called hypertension, and to protect kidney damage from occurring. HCTZ is one of the most frequently prescribed medications in the United States. It's often used to treat fluid retention, high blood pressure or kidney disorders.

Hydroclorothiazide is a diuretic, or water pill. It's commonly prescribed to help your body refrain from retaining too much salt, which in turn helps your level of water retention. However, a common side effect of many diuretics is that they can lead to the loss of too much potassium. As a result, many physicians may prescribe potassium supplementation for patients taking diuretics.

Ask Your Doctor or Pharmacist

If you believe you may be taking one of the affected medications, be sure to contact your physician or pharmacist for more information.

You should not stop taking your medicine, as it can cause a dangerous side effect known as the "rebound effect." This side effect can prove to be more severe than continuing the medication while reaching out to your medical provider for more information.

You can ask your physician or pharmacist about getting a prescription for an alternative medicine. No reports of adverse side effects or illnesses have been reported due to the affected Torrent pharmaceuticals at this time.


Blood Pressure Medication Containing Carcinogen Recalled
 
On Jan. 23, 2019, one of the nation's leading pharmaceutical manufacturers, Torrent Pharmaceuticals, announced a voluntary recall of a popular blood pressure medication.


 
The recalled medication is a combination tablet containing both losartan potassium and hydroclorothiazide, also known as HTCZ. Torrent's voluntary recall now includes a total of 16 lots of these combo tablets.

The medication has been recalled due to trace amounts of a carcinogenic material, Nitrosodiethylamine, or NDEA, being found in the active ingredient losartan.
 
The losartan at issue is an active ingredient that was manufactured at Hetero Labs Limited.

Voluntary Recall Is Only a Precaution

 
Torrent is voluntarily recalling only the medication lots that contain NDEA levels above the recommended levels. The recommended amount of NDEA is not to exceed .27 ppm (parts per million). NDEA is a chemical that has been associated with cancer.

The Food and Drug Administration (FDA) advises the public that any medications that are hydroclorothiazide HCTZ-only or amlodipine-only are not a part of this medicine recall.

Only Combo Tabs Involved in Drug Recall

Pharmaceutical manufacturers have voluntarily recalled high blood medicines that are amlodipine combined with either valsartan or losartan, or HCTZ combined with either valsartan or losartan.

Losartan is commonly prescribed as a way to treat high blood pressure, also called hypertension, and to protect kidney damage from occurring. HCTZ is one of the most frequently prescribed medications in the United States. It's often used to treat fluid retention, high blood pressure or kidney disorders.

Hydroclorothiazide is a diuretic, or water pill. It's commonly prescribed to help your body refrain from retaining too much salt, which in turn helps your level of water retention. However, a common side effect of many diuretics is that they can lead to the loss of too much potassium. As a result, many physicians may prescribe potassium supplementation for patients taking diuretics.

Ask Your Doctor or Pharmacist

If you believe you may be taking one of the affected medications, be sure to contact your physician or pharmacist for more information.

You should not stop taking your medicine, as it can cause a dangerous side effect known as the "rebound effect." This side effect can prove to be more severe than continuing the medication while reaching out to your medical provider for more information.

You can ask your physician or pharmacist about getting a prescription for an alternative medicine. No reports of adverse side effects or illnesses have been reported due to the affected Torrent pharmaceuticals at this time.